These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


338 related items for PubMed ID: 15295667

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Occurrence of nocturnal arterial hypotension in patients with primary open-angle glaucoma and normal tension glaucoma].
    Muzyka M, Nizankowska MH, Koziorowska M, Zajac-Pytrus H.
    Klin Oczna; 1997; 99(2):109-13. PubMed ID: 9379661
    [Abstract] [Full Text] [Related]

  • 3. Relationship of progression of visual field damage to postural changes in intraocular pressure in patients with normal-tension glaucoma.
    Kiuchi T, Motoyama Y, Oshika T.
    Ophthalmology; 2006 Dec; 113(12):2150-5. PubMed ID: 16996611
    [Abstract] [Full Text] [Related]

  • 4. Effect of nocturnal blood pressure reduction on circadian fluctuation of mean ocular perfusion pressure: a risk factor for normal tension glaucoma.
    Choi J, Jeong J, Cho HS, Kook MS.
    Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):831-6. PubMed ID: 16505014
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of dorzolamide 2% added to timolol maleate 0.5% on intraocular pressure, retrobulbar blood flow, and the progression of visual field damage in patients with primary open-angle glaucoma: a single-center, 4-year, open-label study.
    Martínez A, Sánchez M.
    Clin Ther; 2008 Jun; 30(6):1120-34. PubMed ID: 18640468
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of oral brovincamine on visual field damage in patients with normal-tension glaucoma with low-normal intraocular pressure.
    Koseki N, Araie M, Yamagami J, Shirato S, Yamamoto S.
    J Glaucoma; 1999 Apr; 8(2):117-23. PubMed ID: 10209728
    [Abstract] [Full Text] [Related]

  • 9. Influence of myopic refraction on visual field defects in normal tension and primary open angle glaucoma.
    Araie M, Arai M, Koseki N, Suzuki Y.
    Jpn J Ophthalmol; 1995 Apr; 39(1):60-4. PubMed ID: 7643485
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Long-term relationship between intraocular pressure and visual field loss in primary open-angle glaucoma.
    Inatani M, Iwao K, Inoue T, Awai M, Muto T, Koga T, Ogata-Iwao M, Hara R, Futa R, Tanihara H.
    J Glaucoma; 2008 Apr; 17(4):275-9. PubMed ID: 18552612
    [Abstract] [Full Text] [Related]

  • 12. The relation between intraocular pressure peak in the water drinking test and visual field progression in glaucoma.
    Susanna R, Vessani RM, Sakata L, Zacarias LC, Hatanaka M.
    Br J Ophthalmol; 2005 Oct; 89(10):1298-301. PubMed ID: 16170120
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Visual field progression in glaucoma: total versus pattern deviation analyses.
    Artes PH, Nicolela MT, LeBlanc RP, Chauhan BC.
    Invest Ophthalmol Vis Sci; 2005 Dec; 46(12):4600-6. PubMed ID: 16303955
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Visual field damage in normal-tension glaucoma patients with or without ischemic changes in cerebral magnetic resonance imaging.
    Suzuki J, Tomidokoro A, Araie M, Tomita G, Yamagami J, Okubo T, Masumoto T.
    Jpn J Ophthalmol; 2004 Dec; 48(4):340-4. PubMed ID: 15295658
    [Abstract] [Full Text] [Related]

  • 18. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study.
    Nouri-Mahdavi K, Hoffman D, Coleman AL, Liu G, Li G, Gaasterland D, Caprioli J, Advanced Glaucoma Intervention Study.
    Ophthalmology; 2004 Sep; 111(9):1627-35. PubMed ID: 15350314
    [Abstract] [Full Text] [Related]

  • 19. The effect of nimodipine, a centrally active calcium antagonist, on visual function and mascular blood flow in patients with normal-tension glaucoma and control subjects.
    Piltz JR, Bose S, Lanchoney D.
    J Glaucoma; 1998 Oct; 7(5):336-42. PubMed ID: 9786563
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.